Noxopharm Limited
NOXOF · OTC
6/30/2024 | 12/30/2023 | 6/30/2023 | 12/30/2022 | |
|---|---|---|---|---|
| Market Cap | $19,743 | $19,301 | $13,157 | $56,482 |
| - Cash | $2,320 | $5,160 | $3,009 | $11,122 |
| + Debt | $0 | $0 | $0 | $12 |
| Enterprise Value | $17,423 | $14,142 | $10,149 | $45,372 |
| Revenue | $1,794 | $606 | $1,332 | $1,673 |
| % Growth | 196.1% | -54.5% | -20.4% | – |
| Gross Profit | -$1,140 | $605 | -$1,094 | -$1,225 |
| % Margin | -63.5% | 99.9% | -82.1% | -73.2% |
| EBITDA | -$3,471 | -$1,129 | -$2,507 | -$2,738 |
| % Margin | -193.4% | -186.3% | -188.2% | -163.7% |
| Net Income | -$1,080 | -$2,498 | -$4,815 | -$2,713 |
| % Margin | -60.2% | -412.2% | -361.4% | -162.2% |
| EPS Diluted | -0.004 | -0.009 | -0.017 | -0.009 |
| % Growth | 56.5% | 48.5% | -77.4% | – |
| Operating Cash Flow | -$2,822 | $2,138 | -$8,243 | -$1,352 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,822 | $2,138 | -$8,243 | -$1,352 |